Amiodarone-induced thyrotoxicosis

被引：6
|
作者：
Schubert, Louis [1 ]
Bricaire, Leopoldine [1 ]
Groussin, Lionel [1 ,2 ,3 ]
机构：
[1] Hop Cochin, AP HP, Serv Endocrinol, F-75014 Paris, France
[2] Univ Paris, F-75014 Paris, France
[3] Inst Cochin, Inserm Unite 1016, CNRS UMR 8104, F-75014 Paris, France
来源：
ANNALES D ENDOCRINOLOGIE | 2021年 / 82卷 / 3-4期
关键词：
Amiodarone; Thyrotoxicosis; Hyperthyroidism; ASSOCIATION; GUIDELINES; MANAGEMENT; TYPE-2; THYROIDECTOMY; CONTINUATION; THERAPY;
D O I：
10.1016/j.ando.2020.04.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Amiodarone-induced thyrotoxicosis (AIT) are not uncommon endocrinopathies. Clinicians are sometimes faced with difficult diagnostic and therapeutic situations. The disease pathophysiology is partially understood, explaining the lack of predictive factors for occurrence. Different international recommendations for their management have been published: the most recent in 2018 by the European Thyroid Association (ETA) (Ross et al., 2016; Bartalena et al., 2018). The purpose of this paper is to present the essential concepts for their management and to review the literature since 2018. (C) 2020 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：163 / 166
页数：4
相关论文
共 50 条
  • [1] Amiodarone-Induced Thyrotoxicosis - Literature Review & Clinical Update
    Ferraz de Souza, Luciana Vergara
    Campagnolo, Maria Thereza
    Behrmann Martins, Luiz Claudio
    Scanavacca, Mauricio Ibrahim
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2021, 117 (05) : 1038 - 1044
  • [2] Comparison Between Total Thyroidectomy and Medical Therapy for Amiodarone-Induced Thyrotoxicosis
    Cappellani, Daniele
    Papini, Piermarco
    Pingitore, Alessandro
    Tomisti, Luca
    Mantuano, Michele
    Di Certo, Agostino M.
    Manetti, Luca
    Marconcini, Giulia
    Scattina, Ilaria
    Urbani, Claudio
    Morganti, Riccardo
    Marcocci, Claudio
    Materazzi, Gabriele
    Iervasi, Giorgio
    Martino, Enio
    Bartalena, Luigi
    Bogazzi, Fausto
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (01) : 242 - 251
  • [3] Amiodarone-induced thyrotoxicosis
    Piga, M.
    Serra, A.
    Boi, F.
    Tanda, M. L.
    Martinos, E.
    Mariotti, S.
    MINERVA ENDOCRINOLOGICA, 2008, 33 (03) : 213 - 228
  • [4] Management of Amiodarone-Induced Thyrotoxicosis at a Cardiac Transplantation Centre
    Isaacs, Michelle
    Costin, Monique
    Bova, Ron
    Barrett, Helen L.
    Heffernan, Drew
    Samaras, Katherine
    Greenfield, Jerry R.
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [5] Amiodarone-induced thyrotoxicosis
    Kaufmann, C
    Cron, TA
    Meier, C
    Staub, JJ
    Oberholzer, M
    Osswald, S
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 2000, 130 (43) : 1610 - 1617
  • [6] Amiodarone-induced thyrotoxicosis: Should surgery be considered?
    Frey, Samuel
    Caillard, Cecile
    Mahot, Pascale
    Drui, Delphine
    Mirallie, Eric
    ANNALES D ENDOCRINOLOGIE, 2024, 85 (02) : 136 - 141
  • [7] Surgical treatment of amiodarone-induced thyrotoxicosis
    Biermann, E
    Morgenstern, C
    OTO-RHINO-LARYNGOLOGIA NOVA, 1999, 9 (3-4) : 149 - 154
  • [8] Amiodarone-induced thyrotoxicosis following treatment for amiodarone-induced hypothyroidism
    Choi, Sung Rae
    Seaquist, Elizabeth R.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2007, 3 (03) : 359 - 367
  • [9] Amiodarone-induced thyrotoxicosis: A review
    Tsang, Wendy
    Houlden, Robyn L.
    CANADIAN JOURNAL OF CARDIOLOGY, 2009, 25 (07) : 421 - 424
  • [10] Exploring Current Diagnosis and Management of Amiodarone-induced Thyrotoxicosis
    Oktaviono, Yudi Her
    Mustofa, Ali
    Saputra, Pandit Bagus Tri
    Widiarti, Wynne
    Faizah, Novia Nurul
    Alkaff, Firas Farisi
    AMERICAN JOURNAL OF CARDIOLOGY, 2025, 242 : 75 - 81
12345